sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
SKYE
Updated 10/6/2026, 8:26 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| SKYE Skye Bioscience, Inc. | Sale | $239,555 | Schwab Andrew J. Director, 10% owner | 148,079 sh | at $1.62 | Filed Sep 24, 4:31 PM ET | Filing | |
| SKYE Skye Bioscience, Inc. | Sale | $239,555 | 5AM Partners VII, LLC 10% owner and 7 others | 148,079 sh | at $1.62 | Filed Sep 24, 4:29 PM ET | Filing | |
| SKYE Skye Bioscience, Inc. | Sale | $64,734 | Schwab Andrew J. Director, 10% owner | 33,892 sh | at $1.91 | Filed Sep 18, 6:39 PM ET | Filing | |
| SKYE Skye Bioscience, Inc. | Sale | $64,734 | 5AM Partners VII, LLC 10% owner and 7 others | 33,892 sh | at $1.91 | Filed Sep 18, 6:37 PM ET | Filing | |
| SKYE Skye Bioscience, Inc. | Sale | $140,313 | Schwab Andrew J. Director, 10% owner | 375,840 sh | at $0.37 | Filed Aug 20, 5:59 PM ET | Filing | |
| SKYE Skye Bioscience, Inc. | Sale | $140,313 | 5AM Partners VII, LLC 10% owner and 7 others | 375,840 sh | at $0.37 | Filed Aug 20, 5:57 PM ET | Filing |